Pubblicazioni ufficiali Innate Pharma

Azioni

Mercato chiuso - Euronext Paris Altri mercati azionari 17:35:08 05/07/2024			Variaz. 5gg	Var. 1 gen.
2 ^EUR	-2,68%		+6,72%	-23,66%

17/06	Sanofi: dati positivi di fase 1/2 nella leucemia	CF
17/06	Innate: dati positivi di fase 1/2 nella leucemia	CF

Shareholders meeting voting results	23/05	CO
Slide show Q1	14/05	CO
1st quarter turnover	14/05	CO
1st quarter turnover	14/05	CO
General assembly meeting brochure	06/05	CO
Mixed general shareholder meeting	06/05	CO
Mixed general shareholder meeting	15/04	CO
SEC Filing 20 F	04/04	CO
Universal registration document	04/04	CO
Auditors Report	03/04	CO
Slide show results	21/03	CO
Annual results	21/03	CO
Annual results	21/03	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	01/02	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	10/01	CO
Monthly statement on voting rights	01/01	CO
Monthly statement on voting rights	01/01	CO
Changes in management and corporate officers	18/12	CO
Changes in management and corporate officers	18/12	CO
Slide show Q3	14/11	CO
3rd quarter turnover	14/11	CO
3rd quarter turnover	14/11	CO
Monthly statement on voting rights	30/09/23	CO
Monthly statement on voting rights	30/09/23	CO
Slide show half-year results	14/09/23	CO